VolitionRx (VNRX) Institutional Ownership $0.55 +0.00 (+0.89%) As of 03/25/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for VolitionRx (NYSE:VNRX)CurrentInstitutional OwnershipPercentage8.09%Number ofInstitutional Buyers(last 12 months)6TotalInstitutional Inflows(last 12 months)$1.04MNumber ofInstitutional Sellers(last 12 months)0 Get VNRX Insider Trade Alerts Want to know when executives and insiders are buying or selling VolitionRx stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data VNRX Institutional Buying and Selling by Quarter Remove Ads VolitionRx Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025 Millennium Management LLC60,638$36K0.0%N/A0.065% 2/17/2025 Lagoda Investment Management L.P.7,576,000$4.55M2.5%+24.3%8.176% 2/14/2025 Northern Trust Corp117,875$71K0.0%+32.0%0.127% 2/14/2025 Two Sigma Securities LLC48,910$29K0.0%N/A0.053% 11/16/2024 Geode Capital Management LLC730,448$439K0.0%+15.1%0.788% 10/29/2024 Ground Swell Capital LLC45,959$28K0.0%+78.8%0.050% 1/17/2024 Silverberg Bernstein Capital Management LLC147,038$105K0.1%N/A0.187% 11/14/2023 Lagoda Investment Management L.P.3,882,850$2.68M1.8%-1.2%4.969% (Data available from 1/1/2016 forward)Remove Ads VNRX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of VNRX shares? During the previous two years, the following institutional investors and hedge funds held shares of VolitionRx shares: Lagoda Investment Management L.P. ($4.55M), Geode Capital Management LLC ($439K), Silverberg Bernstein Capital Management LLC ($105K), Northern Trust Corp ($71K), Millennium Management LLC ($36K), and Two Sigma Securities LLC ($29K), and Ground Swell Capital LLC ($28K).Learn more on VNRX's institutional investors. What percentage of VolitionRx stock is owned by institutional investors? 8.09% of VolitionRx stock is owned by institutional investors. Learn more on VNRX's institutional investor holdings. Which institutional investors have been buying VolitionRx stock? The following institutional investors have purchased VolitionRx stock in the last 24 months: Lagoda Investment Management L.P. ($1.48M), Silverberg Bernstein Capital Management LLC ($147.04K), Geode Capital Management LLC ($95.90K), Millennium Management LLC ($60.64K), Two Sigma Securities LLC ($48.91K), Northern Trust Corp ($28.58K), and Ground Swell Capital LLC ($20.25K). How much institutional buying is happening at VolitionRx? Institutional investors have bought a total of 1,882,314 shares in the last 24 months. This purchase volume represents approximately $1.15M in transactions. Which VolitionRx major shareholders have been selling company stock? The following institutional investors have sold VolitionRx stock in the last 24 months: Lagoda Investment Management L.P. ($46.26K). How much institutional selling is happening at VolitionRx? Institutional investors have sold a total of 46,260 shares in the last 24 months. This volume of shares sold represents approximately $31.87K in transactions. Related Companies PLX Major Shareholders RAPT Major Shareholders CTNM Major Shareholders CKPT Major Shareholders LFVN Major Shareholders NMRA Major Shareholders CRGX Major Shareholders AMRN Major Shareholders TNGX Major Shareholders OCGN Major Shareholders This page (NYSE:VNRX) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VolitionRx Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share VolitionRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VNRX Stock Free VNRX Stock Alerts